October 2023
Tess Eidem earned her Ph.D. in Microbiology discovering novel antimicrobial compounds against bacterial pathogens, and she has continued to expand her knowledge in and outside of the lab, building a strong background in manufacturing, product safety and quality, and microbial detection and prevention measures with a focus on controlled environment agriculture (CEA) […]
September 2023
Dr. Vandrey is an experimental psychologist with degrees from the University of Delaware (BA) and University of Vermont (PhD). He is currently a Professor at the Behavioral Pharmacology Research Unit (BPRU). Dr. Vandrey’s research focuses primarily on the impact of route of administration, dose, and chemical composition of cannabis products on resultant […]
July 2023
Dr. Jodi Gilman is an Associate Professor in Psychiatry at Harvard Medical School and the Director of Neuroscience at the Massachusetts General Hospital Center for Addiction Medicine. She received her PhD in Neuroscience from Brown University. Dr. Gilman’s research uses multi-modal imaging, behavioral and cognitive testing to understand the biological, psychological, and […]
June 2023
Dr. Reinhold Penner is the Director of Research at The Center for Biomedical Research at The Queen’s Medical Center in Honolulu, Hawaii. He obtained his PhD from the University of Giessen, Germany, in 1986 and spent his Postdoc time until 1990 in the lab of Nobel Laureate Dr. Erwin Neher at the Max-Planck-Institute […]
May 2023
Dr. Tory Spindle obtained his PhD in Experimental Health Psychology from Virginia Commonwealth University. Broadly, Dr. Spindle utilizes human laboratory studies to characterize the behavioral pharmacology of cannabis and individual cannabis constituents. His research seeks to understand how factors such as route of administration (oral, vaped, smoked, topical), dose, product formulation/chemical composition […]
April 2023
Jessica S. Kruger, PhD, MCHES, is a health educator whose research focuses on consumption and addictive behaviors, health behavior decision-making and pedagogy in public health. She collaborates with a wide variety of community-based organizations and advises students at the Lighthouse Free Medical Clinic and the Seneca-Babcock Community Center, both in the Western […]
March 2023
Dr. Adie Rae Wilson-Poe : “The Unintended Negative Impact of Adult-Use Cannabis Legalization on the Wellbeing of Medical Cannabis Patients” Dr. Wilson-Poe received her BS in Psychology and her PhD in Neuroscience from Washington State University, where she focused on the pain-relieving properties of opioids and cannabinoids.
Adie followed up on this […]
February 2023
Ms. Shawn Hauser is a partner at Vicente Sederberg and co-chair of the firm’s Hemp and Cannabinoids Department as well as a leader in the firm’s psychedelics and emerging therapies practice. Shawn helps cannabis, hemp, and psychedelics businesses navigate the intersections between state and federal law including cannabis and psychedelics laws and […]
January 2023
Dr. Tishler is a Cannabis Specialist. Through his training in Internal Medicine and years of practice as an Emergency Physician, Dr. Tishler brings his knowledge, reason, and caring to patients here at inhale MD, and through his advocacy work at the local and national levels. Dr. Tishler graduated from both Harvard College […]
December 2022
Jahan Marcu, Ph.D is one of the top researchers and industry experts in the field, contributing to many innovative discoveries, applications, and standards for medical cannabis and its laboratory analysis, cultivation, manufacturing, and dispensing. He is a court qualified expert witness for cannabis and synthetic drugs, and is cited in case law. […]
How the CB1 cannabinoid receptor communicates within the cell via associated proteins
April 11, 2024, 1 PM MST
Dr. Allyn C. Howlett is a Professor of Physiology and Pharmacology at Wake Forest University School of Medicine, Assistant Dean of WFU Graduate School Biomedical Programs, and Director of the Office of Postdoctoral Education. Dr. […]
From Seed to Synapse: Modeling the Long-Term
Impacts of Developmental Cannabis Exposure
March 14, 2024, 1 PM MST
Dr. Ryan McLaughlin is an Associate Professor in the Department of Integrative Physiology and Neuroscience at Washington State University (WSU). The overarching goal of Dr. McLaughlin’s research program is to determine how endogenous and exogenous cannabinoids […]
The therapeutic promise of non-addicting cannabinoid analgesics
February 2024
Andrea G. Hohmann is a Linda and Jack Gill Chair of Biomolecular Science and Professor of Psychological and Brain Sciences at Indiana University Bloomington. Dr. Hohmann received her Ph.D. from Brown University and completed postdoctoral training at NIMH and NIDCR in functional neuroanatomy and […]
Preclinical Assessment of Cannabinoid-Based Medications for Treatment of Multidimensional Opiod Withdrawal
January 2024
Cassie Moore, PhD is an Assistant Professor in the Division of Behavioral Biology at the Johns Hopkins University School of Medicine. Her research uses animal models to explore the balance between potential benefits and consequences of cannabinoid-based medications. Recent projects […]
December 2023
Jane Metrik, Ph.D., is Professor in the Departments of Behavioral and Social Sciences and Psychiatry and Human Behavior at Brown University based at the Center for Alcohol and Addiction Studies. She holds a joint appointment at the Providence VA Medical Center, as a research scientist and as a licensed clinical psychologist. Trained in […]
November 2023
Dr. Emily Bates is an Associate Professor in the Department of Pediatrics at the University of Colorado School of Medicine. She started her career in research as an undergraduate student at the University of Utah studying developmental signaling in fruit flies. Dr. Bates studied neurodegeneration and ion channel function as a PhD […]